Wynn Hunter
Cardiovascular Disease · Lincoln, NENPI 1346603784
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (47.0%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Medtronic at 49.4% of the total. Among cardiovascular disease clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 121 payments — averaging $378.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$23K
- Boston Scientific$18K
- Abbott$5K
- EBR Systems, Inc.$281
- Biosense Webster, Inc.$181
- Teleflex LLC$65
- plus $76 from 3 others
What the payments were for
- Speaking & faculty fees$12,81328%
- Grants$21,50047%
- Travel & lodging$5,22311%
- Food & beverage$5,85113%
- Education$3541%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 19 | $22,590 |
| Boston Scientific | 51 | $17,828 |
| Abbott | 41 | $4,720 |
| EBR Systems, Inc. | 1 | $281 |
| Biosense Webster, Inc. | 3 | $181 |
| Teleflex LLC | 3 | $65 |
| Chiesi USA, Inc. | 1 | $30 |
| Impulse Dynamics (USA) Inc. | 1 | $27 |
| Edwards Lifesciences | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL EP$12,921
- AVEIR$3,342
- GENERAL - THERAPIES$2,215
- Rhythmia Mapping System$281
- Micra$211
- ENSITE$151
- Carto 3$117
- ASSURITY$102
How this compares
$45,741 in reported general payments places this provider in the 90th percentile of 97 cardiovascular disease providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amiodarone Hcl | 12 | $128 |
| Metoprolol Tartrate | 26 | $18 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Lincoln
- Robert PercellLincoln$918K
- Steven KruegerLincoln$388K
- Keith MillerLincoln$86K
- Gina MentzerLincoln$27K
- Rajeev AnchanLincoln$7K
- Kaliprasad AyalaLincoln$5K
- John SteuterLincoln$4K
- Rebecca RundlettLincoln$3K
- Omar NassLincoln$3K
- Chad TraversLincoln$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.